Regeneron Pharmaceuticals, Inc. (REGN)
789.06
+16.88
(+2.19%)
USD |
NASDAQ |
Feb 25, 12:59
Regeneron Pharmaceuticals Market Cap : 83.42B for Feb. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 207.40B |
| Gilead Sciences, Inc. | 183.16B |
| Johnson & Johnson | 590.55B |
| Eli Lilly & Co. | 974.79B |
| Merck & Co., Inc. | 304.32B |
Market Cap Related Metrics
| PE Ratio | 18.99 |
| PS Ratio | 5.976 |
| PEG Ratio | 2.218 |
| Price to Book Value | 2.669 |
| Price to Free Cash Flow | 22.76 |
| Price | 789.06 |
| Earnings Yield | 5.27% |
| PEGY Ratio | 2.104 |
| Operating PE Ratio | 23.15 |
| Normalized PE Ratio | 19.38 |